agreement among healthcare professionals in diagnosing case vignette-based surgical site infections...
TRANSCRIPT
Agreement among healthcare professionals in diagnosing case vignette-based
surgical site infections in 10 European countries.
G. Birgand 1, D. Lepelletier 2, G. Baron 3, S. Barrett 4, A-C Breier 5, C. Buke 6, L. Markovic-Denic 7, P. Gastmeier 5, J. Kluytmans 8, O. Lyytikainen 9,
E. Sheridan 10, E. Szilagyi 11, E. Tacconelli 12, N. Troillet 13, P. Ravaud 3, JC Lucet 1 and the VARSSI study group
1 Infection control unit, Bichat-Claude Bernard Hospital, Paris, France; 2 Hygiene Department, Nantes University Hospital, France; 3 Centre d’Épidémiologie Clinique, Hôpital Hôtel Dieu, Paris, France; 4 Medical microbiology and infection control, Southend
Hospital, UK; 5 Institute of Hygiene and Environmental Medicine, Charité - University Medicine Berlin, Germany; 6 Department of Infectious Diseases and Clinical Microbiology, Ege University Medical Faculty, Izmir, Turkey; 7 Institute of epidemiology, Faculty of
Medicine, University of Belgrade, Serbia; 8 Medical microbiology and infection control, Amphia medical center Breda, The Netherlands; 9 Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare (THL),
Helsinki, Finland; 10 Department of Healthcare-Associated Infection and Antimicrobial Resistance, HPA Centre for Infections, London, UK; 11 Department of Epidemiology, Budapest, Hungary; 12 Department of Infectious Diseases, Università Cattolica del
Sacro Cuore, Rome, Italy; 13 Department of infectious diseases, Central Institute, Valais Hospital, Sion, Switzerland.
Disclosure statement
• Financial support: – French Ministry of Health (national grant PREQHOS 0901)
• Conflict of interest:– Pfizer: Travel grant for the ICAAC 2011
G Birgand VARSSI study
ECCMID Berlin 2013
Background• Public reporting of HAI to improve public information and
performance: process indicators or infection rates
• However, SSI rates vary according to several factors – Co-morbidities, contamination class, conditions of the surgical
procedure – Robustness of SSI rates depends on definitions, training, and experience
• Recent studies:– Wilson AP, BMJ 2004: variable interpretations of definitions – French study: disagreement among healthcare professionals in SSI
diagnosis using case-vignettes (Lepelletier , Plos one 2012)– European network: large differences in SSI recognition across countries
(Wilson J, JHI 2007)
G Birgand VARSSI study
Objectives
• To assess agreement in SSI diagnosis among Infection Control Physicians (ICPs) and surgeons involved in SSI surveillance in 10 European countries
- Main objective = intra-country/intra-specialty variability- Secondary objective = intra-specialty/inter-country
variability- Criteria n°1: presence/absence of SSI- Criteria n°2: depth
• To assess the impact of SSI definition availability on diagnosis
G Birgand VARSSI study
ECCMID Berlin 2013
10 participating countriesG Birgand VARSSI study
MethodsElaboration of case vignettes
• 20 case vignettes built from patients hospitalised in 6 surgical units of 3 French university hospitals– Cardiac (n=5), Digestive (n=5), Orthopedic (n=4), ENT
(n=2), Gynecology (n=2) and Neurosurgery (n=2)– Wound discharge and/or infectious signs – Bedside evaluation with collection of biological,
bacteriological and radiological signs
• Case vignettes standardised by the same investigator– Same chronological information – Internet-secured relational database with personal login
and password
ECCMID Berlin 2013
G Birgand VARSSI study
G Birgand VARSSI study
20 vignettes
10 ICPs x 8 vignettes
10 Surgeons x 8 vignettes
20 x 4 = 80 readings per specialty
160 readings per country
X10 countries
1600 readings
1 2 3 4 5 6 7
No SSI SSI
SSI certainly absent
SSI certainly present
Existence of SSI
Intra-class correlation coefficient (ICC) with 95%CI
Methods
G Birgand VARSSI study
ECCMID Berlin 2013
1 2 3 4 5 6 7
1
2
3
No SSI SSI
SSI certainly absent
SSI certainly present
Superficial SSI
Deep or organ/space SSI
Don’t know
Existence of SSI
Intra-class correlation coefficient (ICC) with 95%CI
Depth of SSI
kappa coefficient (kC) with 95%CI
Methods
G Birgand VARSSI study
MethodsInterpretation of agreement
• Intra-correlation coefficient (presence/absence of SSI) – < 0.40 = poor agreement– 0.41-0.71 = good agreement– > 0.71 = excellent agreement
• Kappa coefficient (SSI depth) – < 0.40 = poor agreement– 0.41-0.60 = fair agreement– 0.61-0.80 = good agreement– > 0.81 = excellent agreement
Landis JR. Biometrics 1977
Nunnally JC. Psychometric theory 1994
G Birgand VARSSI study
ECCMID Berlin 2013
Number of participants
10 ICPs + 10 Surgeons
10 ICPs + 4 Surgeons
10 ICPs + 9 Surgeons
100 ICPs and 86 Surgeons
G Birgand VARSSI study
ResultsAssessment of agreement about SSI diagnosis
G Birgand VARSSI study
Intra-country correlation
N
SSI diagnosis scoring, 7-point Likert scaleIntra-correlation coefficient ICC
ICP
Turkey 80 + 80 0.44
Serbia 80 + 80 0.26
Hungary 80 + 80 0.28
Italy 80 + 72 0.31
Germany 80 + 80 0.65
Finland 80 + 80 0.30
Netherlands 80 + 32 0.45
Switzerland 80 + 80 0.40
France 80 + 72 0.44
UK 80 + 32 0.59
Inter-country 1488 0.41
G Birgand VARSSI study
ResultsAssessment of agreement about SSI diagnosis
Intra-country correlation
N
SSI diagnosis scoring, 7-point Likert scaleIntra-correlation coefficient ICC
ICP Surgeons
Turkey 80 + 80 0.44 0.23
Serbia 80 + 80 0.26 0.06
Hungary 80 + 80 0.28 0.24
Italy 80 + 72 0.31 0.08
Germany 80 + 80 0.65 0.46
Finland 80 + 80 0.30 0.21
Netherlands 80 + 32 0.45 0.00
Switzerland 80 + 80 0.40 0.08
France 80 + 72 0.44 0.30
UK 80 + 32 0.59 0.04
Inter-country 1488 0.41 0.24
Intra-country correlation
N
SSI diagnosis scoring, 7-point Likert scaleIntra-correlation coefficient ICC
ICP Surgeons All
Turkey 80 + 80 0.44 0.23 0.23
Serbia 80 + 80 0.26 0.06 0.20
Hungary 80 + 80 0.28 0.24 0.31
Italy 80 + 72 0.31 0.08 0.20
Germany 80 + 80 0.65 0.46 0.55
Finland 80 + 80 0.30 0.21 0.30
Netherlands 80 + 32 0.45 0.00 0.42
Switzerland 80 + 80 0.40 0.08 0.26
France 80 + 72 0.44 0.30 0.41
UK 80 + 32 0.59 0.04 0.04
Inter-country 1488 0.41 0.24 0.24
G Birgand VARSSI study
ResultsAssessment of agreement about SSI diagnosis
No impact of definition on the agreement between participants regarding the presence of SSI
ResultsAssessment of agreement about SSI depth
G Birgand VARSSI study
CountriesSSI depth, 4-point scale (Kappa coefficient)
ICP
Turkey 0.26
Serbia 0.05
Hungary 0.20
Italy 0.23
Germany 0.50
Finland 0.27
Netherlands 0.25
Switzerland 0.34
France 0.44
UK 0.38
Inter-country 0.28
ResultsAssessment of agreement about SSI depth
G Birgand VARSSI study
CountriesSSI depth, 4-point scale (Kappa coefficient)
ICP Surgeons
Turkey 0.26 0.25
Serbia 0.05 0.05
Hungary 0.20 0.16
Italy 0.23 0.09
Germany 0.50 0.31
Finland 0.27 0.14
Netherlands 0.25 0.17
Switzerland 0.34 0.14
France 0.44 0.17
UK 0.38 0.19
Inter-country 0.28 0.19
CountriesSSI depth, 4-point scale (Kappa coefficient)
ICP Surgeons All
Turkey 0.26 0.25 0.27
Serbia 0.05 0.05 0.09
Hungary 0.20 0.16 0.19
Italy 0.23 0.09 0.31
Germany 0.50 0.31 0.35
Finland 0.27 0.14 0.25
Netherlands 0.25 0.17 0.25
Switzerland 0.34 0.14 0.24
France 0.44 0.17 0.27
UK 0.38 0.19 0.34
Inter-country 0.28 0.19 -
ResultsAssessment of agreement about SSI depth
G Birgand VARSSI study
No impact of definition on the agreement between participants
regarding SSI depth
Discussion• Large disagreement among healthcare professionals in SSI
diagnosis:– varied both between and within specialties
need for a multidisciplinary approach
• One country (Germany) with the best agreement – Regular cross-hospital evaluation of diagnosis accuracy through
surveillance network
• Limitations:– SSI diagnosis made by individuals without teamwork– Scoring via an online database without contact with patients– Selection bias (recruitment by European leaders of participants
presumed to be expert on this topic)
G Birgand VARSSI study
Conclusion
• Original approach to assess the variability of SSI diagnosis– Large panel of ICPs and surgeons in 10 European countries
• SSI rates should be used with caution for benchmarking or public reporting
• SSI surveillance and feedback remain important tools for SSI prevention– Further studies are needed to improve agreement
regarding the SSI diagnosis
G Birgand VARSSI study
ECCMID Berlin 2013
Aknowledgment• The VARSSI study group:
– Turkish, Finnish, Hungarian, German, Italian, Serbian, Swiss, Duch, British and French ICPs and Surgeons participants
• Participating wards:– Pr Nataf, Cardiac surgery, Pr Marmuse, Digestive
surgery; Pr Massin, Orthopedic surgery, Bichat-Claude Bernard University Hospital
– Pr Despins, Cardiac Surgery, University Hospital, Nantes;
G Birgand VARSSI study
ECCMID Berlin 2013
Thank you for your attention
ResultsDistribution of scores
Countries NInfect Contr Phys Surgeons
Median (IQR) Median (IQR)
Turkey 80 + 80 6 (4 - 7) 7 (4 - 7)
Serbia 80 + 80 7 (3 - 7) 6 (3 - 7)
Hungary 80 + 80 6 (4 - 7) 7 (3 - 7)
Italy 80 + 72 6 (4 - 7) 6 (3 - 7)
Germany 80 + 80 7 (3.5 - 7) 6 (3 - 7)
Finland 80 + 80 6 (3 - 7) 6 (3 - 7)
Netherlands 80 + 32 6 (3 - 7) 6 (4 - 7)
Switzerland 80 + 80 7 (4.5 - 7) 7 (6 - 7)
France 80 + 72 6 (3 - 7) 5 (2 - 7)
UK 80 + 32 6 (4 - 7) 6 (4.5 - 7)
Total 1488 6 (4 - 7) 6 (3 - 7)
G Birgand VARSSI study
ResultsDistribution of scores
Countries NInfect Contr Phys Surgeons
Median (IQR) Min-Max Median (IQR) Min-Max
Turkey 80 + 80 6·0 (4·0-7·0) 1·0-7·0 7·0 (4·0-7·0) 1·0-7·0
Serbia 80 + 80 7·0 (3·0-7·0) 1·0-7·0 6·0 (3·0-7·0) 1·0-7·0
Hungary 80 + 80 6·0 (4·0-7·0) 1·0-7·0 7·0 (3·0-7·0) 1·0-7·0
Italy 80 + 72 6·0 (4·0-7·0) 1·0-7·0 6·0 (3·0-7·0) 1·0-7·0
Germany 80 + 80 7·0 (3·5-7·0) 1·0-7·0 6·0 (3·0-7·0) 1·0-7·0
Finland 80 + 80 6·0 (3·0-7·0) 1·0-7·0 6·0 (3·0-7·0) 1·0-7·0
Netherlands 80 + 32 6·0 (3·0-7·0) 1·0-7·0 6·0 (4·0-7·0) 2·0-7·0
Switzerland 80 + 80 7·0 (4·5-7·0) 1·0-7·0 7·0 (6·0-7·0) 1·0-7·0
France 80 + 72 6.0 (3.0-7.0) 1·0-7·0 5.0 (2.0-7.0) 1·0-7·0
UK 80 + 32 6·0 (4·0-7·0) 1·0-7·0 6·0 (4·5-7·0) 1·0-7·0
Total 1488 6·0 (4·0-7·0) 1·0-7·0 6·0 (3·0-7·0) 1·0-7·0
G Birgand VARSSI study
Intra-country correlation
N
SSI diagnosis scoring, 7-point Likert scaleIntra-correlation coefficient ICC
ICP Spontaneous
scoring
Surgeons Spontaneous
scoring
AllSpontaneous
scoring
Turkey 80 + 80 0·44 (0·22-0·68) 0·23 (0·03-0·50) 0·23 (0·03-0·50)
Serbia 80 + 80 0·26 (0·05-0·53) 0·06 (0·00-0·35) 0·20 (0·04-0·41)
Hungary 80 + 80 0·28 (0·07-0·54) 0·24 (0·04-0·51) 0·31 (0·16-0·54)
Italy 80 + 72 0·31 (0·10-0·57) 0·08 (0·00-0·36) 0·20 (0·07-0·42)
Germany 80 + 80 0·65 (0·45-0·82) 0·46 (0·23-0·69) 0·55 (0·37-0·74)
Finland 80 + 80 0·30 (0·09-0·57) 0·21 (0·01-0·48) 0·30 (0·15-0·52)
Netherlands 80 + 32 0·45 (0·23-0·69) 0·00 (0·00-0·35) 0·42 (0·23-0·65)
Switzerland 80 + 80 0·40 (0·18-0·65) 0·08 (0·00-0·34) 0·26 (0·12-0·48)
France 80 + 72 0·44 (0·22-0·68) 0·30 (0·07-0·57) 0·41 (0·24-0·63)
UK 80 + 32 0·59 (0·38-0·80) 0·04 (0·00-0·62) 0·04 (0·00-0·62)
Inter-country 1488 0·41 (0·28-0·61) 0·24 (0·14-0·42) 0·24 (0·14-0·42)
G Birgand VARSSI study
ResultsAssessment of agreement about SSI diagnosis
Countries
SSI depth, 4-point scale(Kappa coefficient)
Not scored ICP Not
scored Surgeons Not scored All
Turkey 19 0·26 (0·21-0·31) 17 0·25 (0·20-0·30) 36 0·27 (0·24-0·30)
Serbia 21 0·05 (0·00-0·10) 25 0·05 (0·00-0·10) 46 0·09 (0·07-0·11)
Hungary 18 0·20 (0·15-0·25) 22 0·16 (0·10-0·22) 40 0·19 (0·16-0·22)
Italy 21 0·23 (0·17-0·29) 23 0·09 (0·01-0·17) 44 0·31 (0·18-0·34)
Germany 20 0·50 (0·45-0·55) 21 0·31 (0·26-0·36) 41 0·35 (0·32-0·38)
Finland 24 0·27 (0·22-0·32) 23 0·14 (0·09-0·19) 47 0·25 (0·22-0·28)
Netherlands 23 0·25 (0·20-0·30) 7 0·17 (0·00-0·34) 30 0·25 (0·18-0·32)
Switzerland 11 0·34 (0·28-0·40) 18 0·14 (0·08-0·20) 29 0·24 (0·21-0·27)
France 21 0·44 (0·39-0·49) 27 0·17 (0·09-0·25) 48 0·27 (0·23-0·31)
UK 20 0·38 (0·32-0·44) 6 0·19 (-0·02-0·40) 26 0·34 (0·25-0·42)
Inter-country 198 0·28 (0·27-0·29) 189 0·19 (0·17-0·21) - -
ResultsAssessment of agreement about SSI depth
G Birgand VARSSI study